Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Coronavirus Vaccine Research
US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine Boosters
IANS
Jun 3, 2021 12:45 PM +05:30 IST
Road To Atmanirbhar Bharat: Dr. Harsh Vardhan On India As A Healthcare Hub
Swarajya Videos
Jan 22, 2021 02:44 PM +05:30 IST
Australia Abandons Efforts To Develop Homegrown Covid-19 Vaccine After Volunteers In Trials Develop Antibodies For HIV
Swarajya Staff
Dec 14, 2020 09:57 AM +05:30 IST
Chennai Volunteer Claims Neurological Complications From Covid Test Vaccine, Serum Institute Says Symptoms Not Related To Vaccine Trials
Swarajya Staff
Dec 1, 2020 04:54 PM +05:30 IST
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSK
Swarajya Staff
Sep 25, 2020 07:22 PM +05:30 IST
Govt Plans To Issue E-Certificates To Vaccinated Individuals Once An Effective Vaccine Is Developed
Swarajya Staff
Sep 19, 2020 01:05 PM +05:30 IST
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Swarajya Staff
Sep 13, 2020 05:17 PM +05:30 IST
Safe So Far: Bharat Biotech - ICMR's Covaxin Shows No Adverse Effects In Preliminary Phase I Results
Swarajya Staff
Aug 14, 2020 08:50 AM +05:30 IST
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine
Swarajya Staff
Aug 12, 2020 12:07 PM +05:30 IST
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be Dosed
Swarajya Staff
Jul 27, 2020 08:19 PM +05:30 IST
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
Swarajya Staff
Jul 22, 2020 05:55 PM +05:30 IST
Serum Institute To Start Human Trials For Oxford Vaccine In India From August
Swarajya Staff
Jul 21, 2020 10:06 AM +05:30 IST
‘Positive News’ On Oxford Coronavirus Vaccine, Now Undergoing Phase III Human Trials, Likely To Come As Early As Today
Swarajya Staff
Jul 16, 2020 01:32 PM +05:30 IST
Moderna Coronavirus Vaccine Induced Desired Immune Response In All 45 People Evaluated, Phase-3 Clinical Trial Soon
Swarajya Staff
Jul 15, 2020 01:23 PM +05:30 IST
COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next Week
Swarajya Staff
Jul 7, 2020 05:57 PM +05:30 IST
US Green Signals Four Candidate COVID-19 Vaccines For Clinical Trials; Six More Under Review
Swarajya Staff
Jul 1, 2020 11:14 AM +05:30 IST
First Volunteer Who Receives Imperial College’s RNA-based COVID-19 Vaccine In Good Health, Trials Enters Next Phase
Swarajya Staff
Jun 24, 2020 12:22 PM +05:30 IST
Here Is A List Of Seven Organisations In The Race To Develop A Coronavirus Vaccine
Swarajya Staff
May 19, 2020 05:45 PM +05:30 IST
Coronavirus Vaccine Developed By US Biotech Firm Moderna Produces COVID-19 Antibodies in All 45 Participants
Swarajya Staff
May 19, 2020 11:33 AM +05:30 IST
Glenmark Pharma Begins Phase 3 Of Clinical Trials For Favipiravir, Potential COVID-19 Drug In India
Swarajya Staff
May 12, 2020 01:36 PM +05:30 IST
Load More